Dowdy Jackson

2.2k total citations
15 papers, 1.7k citations indexed

About

Dowdy Jackson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Dowdy Jackson has authored 15 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Oncology. Recurrent topics in Dowdy Jackson's work include Angiogenesis and VEGF in Cancer (9 papers), Axon Guidance and Neuronal Signaling (7 papers) and HER2/EGFR in Cancer Research (6 papers). Dowdy Jackson is often cited by papers focused on Angiogenesis and VEGF in Cancer (9 papers), Axon Guidance and Neuronal Signaling (7 papers) and HER2/EGFR in Cancer Research (6 papers). Dowdy Jackson collaborates with scholars based in United States, South Korea and United Kingdom. Dowdy Jackson's co-authors include Jin Chen, Dana M. Brantley‐Sieders, Rebecca S. Muraoka-Cook, Guanglei Zhuang, Osamu Ohmori, Douglas Pat Cerretti, Nikki Cheng, Dana M. Brantley, Wei Bin Fang and John J. Kotyk and has published in prestigious journals such as Journal of Clinical Investigation, Molecular and Cellular Biology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Dowdy Jackson

15 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dowdy Jackson United States	14	1.0k	634	503	439	276	15	1.7k
Svenja Riedle Germany	16	1.1k 1.1×	250 0.4×	521 1.0×	307 0.7×	414 1.5×	17	1.9k
Klaus Edvardsen Denmark	24	781 0.7×	185 0.3×	419 0.8×	206 0.5×	163 0.6×	40	1.6k
Giuliana Pelicci Italy	20	2.2k 2.1×	233 0.4×	810 1.6×	345 0.8×	201 0.7×	37	2.9k
Hua Miao United States	9	2.0k 1.9×	869 1.4×	684 1.4×	393 0.9×	130 0.5×	11	2.6k
Y Yarden Israel	11	1.0k 1.0×	161 0.3×	833 1.7×	255 0.6×	149 0.5×	15	1.7k
Vassiliki Kostourou United Kingdom	16	878 0.8×	121 0.2×	254 0.5×	282 0.6×	441 1.6×	27	1.4k
Jill Wykosky United States	13	904 0.9×	548 0.9×	397 0.8×	327 0.7×	41 0.1×	25	1.7k
Dominique B. Hoelzinger United States	18	1.2k 1.1×	202 0.3×	499 1.0×	353 0.8×	128 0.5×	27	2.1k
Wendy S. McDonough United States	18	1.2k 1.1×	222 0.4×	367 0.7×	355 0.8×	159 0.6×	20	1.8k
Christine Tan United States	10	1.2k 1.1×	154 0.2×	487 1.0×	187 0.4×	75 0.3×	17	1.9k

Countries citing papers authored by Dowdy Jackson

Since Specialization

Citations

This map shows the geographic impact of Dowdy Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dowdy Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dowdy Jackson more than expected).

Fields of papers citing papers by Dowdy Jackson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dowdy Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dowdy Jackson. The network helps show where Dowdy Jackson may publish in the future.

Co-authorship network of co-authors of Dowdy Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Dowdy Jackson. A scholar is included among the top collaborators of Dowdy Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dowdy Jackson. Dowdy Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Jackson, Dowdy, et al.. (2024). The Highs, Lows, and Resurgence of Antibody-drug Conjugates. 1 indexed citations

Jackson, Dowdy & David R. Stover. (2014). Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates. Pharmaceutical Research. 32(11). 3458–3469. 28 indexed citations

Lee, Jeong‐Won, Rebecca L. Stone, Sun Joo Lee, et al.. (2010). EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma. Clinical Cancer Research. 16(9). 2562–2570. 57 indexed citations

Zhuang, Guanglei, Dana M. Brantley‐Sieders, David Vaught, et al.. (2009). Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy. Cancer Research. 70(1). 299–308. 170 indexed citations

Lee, Jeong‐Won, Hee Dong Han, Mian M.K. Shahzad, et al.. (2009). EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma. JNCI Journal of the National Cancer Institute. 101(17). 1193–1205. 63 indexed citations

Leow, Ching Ching, Jon Chesebrough, Karen Coffman, et al.. (2009). Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2–positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib. Molecular Cancer Therapeutics. 8(8). 2131–2141. 34 indexed citations

Brantley‐Sieders, Dana M., Guanglei Zhuang, Donna J. Hicks, et al.. (2008). The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. Journal of Clinical Investigation. 118(1). 64–78. 223 indexed citations

Jackson, Dowdy, John Gooya, Shenlan Mao, et al.. (2008). A Human Antibody–Drug Conjugate Targeting EphA2 Inhibits Tumor GrowthIn vivo. Cancer Research. 68(22). 9367–9374. 121 indexed citations

Shi, Qing, Anita B. Hjelmeland, Stephen T. Keir, et al.. (2007). A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Molecular Carcinogenesis. 46(6). 488–496. 159 indexed citations

10.

Liu, Ta-Jen, Tiffany A. LaFortune, Toshiyuki Honda, et al.. (2007). Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Molecular Cancer Therapeutics. 6(4). 1357–1367. 185 indexed citations

11.

Wiederschain, Dmitri, Lin Chen, Brett V. Johnson, et al.. (2007). Contribution of Polycomb Homologues Bmi-1 and Mel-18 to Medulloblastoma Pathogenesis. Molecular and Cellular Biology. 27(13). 4968–4979. 90 indexed citations

12.

Cheng, Nikki, Dana M. Brantley, Wei Bin Fang, et al.. (2003). Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors. Neoplasia. 5(5). 445–456. 79 indexed citations

13.

Brantley, Dana M., Nikki Cheng, Qing Lin, et al.. (2002). Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene. 21(46). 7011–7026. 263 indexed citations

14.

Anderson, Stasia A., Randall K. Rader, William Westlin, et al.. (2000). Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles. Magnetic Resonance in Medicine. 44(3). 433–439. 209 indexed citations

15.

Jackson, Dowdy & Daniel I. H. Linzer. (1997). Proliferin Transport and Binding in the Mouse Fetus¹. Endocrinology. 138(1). 149–155. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact